Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03116009 · ClinicalTrials.gov registry record · Phase 3
Randomization of Early Diabetes Screening Among Obese Pregnant Women.
A Phase 3 study, sponsored by University of Illinois at Chicago.
- Terminated
- Registry status
- Phase 3
- Development phase
- 600
- Enrollment target
NCT03116009: Clinical Trial Phase 3 study, sponsored by University of Illinois at Chicago.
NCT03116009 is a Phase 3 study that was terminated before completion, run by University of Illinois at Chicago. The registered enrollment target is 600 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (22% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03116009, a Phase 3 study, was terminated before completion, sponsored by University of Illinois at Chicago.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 600 participants
- Enrollment target
Study Summary
This will be a randomization of two groups of obese pregnant women into early screening for diabetes mellitus at the time of their first or subsequent prenatal visits before 20 weeks of gestation versus standard time of screening for diabetes at 24 - 28 weeks as it is done for all pregnant women. The perinatal outcomes between the two groups will be compared to determine whether early screening for diabetes in all obese pregnant women has a clinical merit or significant.
Primary Outcome
Birth weight of newborn more than 90 percentile or birth weight of 4000gm or more will be assessed at the completion of that pregnancy.
Interventions
- DRUG Screening for diabetes with 1-hour GCT and HbA1
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2017-03-19 |
| Est. Completion | 2019-11-25 |
| Phase | Phase 3 |
Why NCT03116009 stopped before completion
NCT03116009 is an interventional study that assigns participants to a tested intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (22% lower).
The record links to 0 conditions, and to 1 intervention - of which Screening for diabetes with 1-hour GCT and HbA1 is the first listed.
NCT03116009 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03116009 about?
NCT03116009 is a clinical study titled "Randomization of Early Diabetes Screening Among Obese Pregnant Women.". This will be a randomization of two groups of obese pregnant women into early screening for diabetes mellitus at the time of their first or subsequent prenatal visits before 20 weeks of gestation versus standard time of screening for diabetes at 24 - 28 weeks as it is done for all pregnant women. Th...
What is the current status of trial NCT03116009?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 600 participants. The study started on 2017-03-19. Estimated completion is 2019-11-25.
What interventions are being tested in trial NCT03116009?
The interventions under investigation include: Screening for diabetes with 1-hour GCT and HbA1 (DRUG).
Who is sponsoring clinical trial NCT03116009?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03116009's enrollment target sits among peer trials
600 608th of 2000 higher than 1,363 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI